1. 130: Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS Trust. (January 2015) Authors: Hill, E.; Higgins, G.; Vallis, K.; Stuart, R.; Drummond, L.; Buckle, A.; Panakis, N. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 144 Audit of palliative whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) treated at the Oxford Cancer Centre over 2½ years. (January 2016) Authors: Shakir, R.; Buffa, F.; Higgins, G.; Horne, A.; Stuart, R.; Vallis, K.; Panakis, N. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK. Issue 1 (January 2022) Authors: Banfill, K.; Croxford, W.; Fornacon-Wood, I.; Wicks, K.; Ahmad, S.; Britten, A.; Carson, C.; Dorey, N.; Hatton, M.; Hiley, C.; Thippu Jayaprakash, K.; Jegannathen, A.; Koh, P.; Panakis, N.; Peedell, C.; Pope, A.; Powell, C.; Stilwell, C.; Thomas, B.; Toy, E. Journal: Clinical oncology Issue: Volume 34:Issue 1(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0747: Validation of the survival model including cardiac substructure dosimetry in NSCLC. (April 2018) Authors: Vivekanandan, S.; Panakis, N.; Higgins, G.S.; Stuart, R.; Landau, D.B.; Cooke, R.; Chu, K.Y.; Fresen, J.; Fenwick, J.D.; Hawkins, M.A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic. (August 2021) Authors: croxford, W.; Banfill, K.; Fornacon-Wood, I.; Britten, A.; Carson, C.; Hatton, M.; Thippu Jayaprakash, K.; Jegannathen, A.; Keng Koh, P.; Panakis, N.; Peedell, C.; Pope, A.; Powell, C.; Stilwell, C.; Thomas, B.; Wood, V.; Yun Zhou, S.; Price, G.; Faivre-Finn, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Stereotactic ablative radiotherapy (SABR) for early stage, non-small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC). (January 2020) Authors: Pascal, L.; O'Cathail, S.; Higgins, G.; Ajzensztejn, D.; Stuart, R.; Panakis, N. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Survival Outcomes Following Concomitant Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC) at Oxford University. (March 2022) Authors: Johnstone, P.; Charlton, P.; Ajzensztejn, D.; Higgins, G.; Stuart, R.; Panakis, N. Journal: Clinical oncology Issue: Volume 34(2022)Supplement 1 Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗